Corbus Pharmaceuticals Holdings, Inc. (CRBP) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Net income	-42.3	-45.6	-111.3	-71.5	-55.7	-32.4	-20.0	-8.9
Depreciation and amortization [+]	0.8	1.0	1.1	0.7	0.5	0.3	0.1	0.0
Depreciation	0.8	1.0	1.1	0.7	0.5	0.3	0.1	0.0
Stock-based compensation	5.7	9.5	12.5	12.0	7.6	5.7	3.2	1.2
Change in working capital [+]	-2.8	-16.5	-3.5	14.2	17.4	0.7	3.2	3.0
Accounts receivable				5.0	12.5	1.0	-1.0
Other current assets							-0.6	-0.1
Accounts payable	-0.3	-6.0	-3.5	4.4	3.9	-0.9	1.9	1.0
Accrued expenses	-4.1	-11.9	-0.4	12.6	5.1	1.5	2.7	0.3
Deferred revenues				-6.5	-4.8		0.1	1.9
Other	1.6	1.4	0.3	-1.2	0.7	-1.0	0.1
Other operating activities	1.1	3.5	1.5	-1.2	0.1	-2.0	0.0	0.0
Cash from operations	-37.5	-48.2	-99.7	-45.7	-30.1	-27.8	-13.6	-4.6

Capital expenditures [+]	0.0	-0.1	-0.5	-2.7	-2.3	-0.7	-0.4	-0.1
Purchases of property and equipment	0.0	-0.1	-0.5	-2.7	-2.3	-0.7	-0.4	-0.1
Sales of property and equipment	0.0	0.0
Other cash from investing	30.1	-73.4
Cash from investing	30.1	-73.4	-0.5	-2.7	-2.3	-0.7	-0.4	-0.1

Issuance of common stock, net		62.6	142.2	40.7	12.1	78.9	16.7	11.3
Other cash from financing	-0.5	-1.8	12.7	-2.2	-0.6	-2.9	0.0	-0.5
Cash from financing	-0.5	60.8	154.9	38.5	11.4	76.0	16.7	10.8

Free cash flow	-37.6	-48.2	-100.2	-48.5	-32.4	-28.5	-13.9	-4.7
Per share (diluted)	($9.01)	($11.78)	($1.28)	($0.76)	($0.57)	($0.57)	($0.34)	($0.15)

Cash paid for interest	2.0	1.7	0.6	0.0	0.0	0.0	0.0